Crispr Therapeutics (CRSP) is down -9.2%, or -$5.38 to $53.40.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Midday Fly By: HP Enterprise reports Q1 beat, BioNTech announces new company
- Crispr Therapeutics announces proposed convertible senior notes offering
- Crispr Therapeutics AG Surges on Takeover Buzz and Hype
- Crispr Therapeutics rumor highlighted in Betaville blog
- Cathie Wood Loads Up on Biotech Stocks While Trimming Several Tech Positions